Birdwatch Note
2023-08-18 11:04:52 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Die Darstellung, dass Ivermectin "nicht für Menschen geeignet" sei, ist irreführend. Es wird auch Menschen regulär gegen parasitäre Infektionskrankheiten verschrieben: https://dermanostic.com/wirkstoffe/ivermectin/ Gegen COVID-19 hingegen hat Ivermectin allen seriösen Studien nach tatsächl. keine nachweisbare Wirkung: https://www.aerzteblatt.de/nachrichten/131973/COVID-19-Studie-findet-erneut-keinen-Wirkungsbeleg-fuer-Ivermectin
Written by 4F1F86DC11937B51BBD2A537F5D94EA5680652E51E39382227389D3CF0CC233F
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1692470348032160242
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1692492753655955747
- noteId - 1692492753655955747
- participantId -
- noteAuthorParticipantId - 4F1F86DC11937B51BBD2A537F5D94EA5680652E51E39382227389D3CF0CC233F Participant Details
- createdAtMillis - 1692356692123
- tweetId - 1692470348032160242
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Die Darstellung, dass Ivermectin "nicht für Menschen geeignet" sei, ist irreführend. Es wird auch Menschen regulär gegen parasitäre Infektionskrankheiten verschrieben: https://dermanostic.com/wirkstoffe/ivermectin/ Gegen COVID-19 hingegen hat Ivermectin allen seriösen Studien nach tatsächl. keine nachweisbare Wirkung: https://www.aerzteblatt.de/nachrichten/131973/COVID-19-Studie-findet-erneut-keinen-Wirkungsbeleg-fuer-Ivermectin
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-08-18 11:04:52 UTC (1692356692123) |
2023-08-18 18:12:19 UTC (1692382339965) |
CURRENTLY_RATED_HELPFUL | 2023-08-20 02:11:21 UTC (1692497481502) |
CURRENTLY_RATED_HELPFUL | 2023-08-18 18:12:19 UTC (1692382339965) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2023-08-19 15:02:40 -0500 | Rating Details | |
| 2023-08-19 10:43:57 -0500 | Rating Details | |
| 2023-08-19 10:24:12 -0500 | Rating Details | |
| 2023-08-19 09:33:34 -0500 | Rating Details | |
| 2023-08-19 09:14:51 -0500 | Rating Details | |
| 2023-08-19 08:31:28 -0500 | Rating Details | |
| 2023-08-19 04:10:07 -0500 | Rating Details | |
| 2023-08-19 03:45:59 -0500 | Rating Details | |
| 2023-08-19 02:02:06 -0500 | Rating Details | |
| 2023-08-19 01:48:48 -0500 | Rating Details | |
| 2023-08-18 20:26:06 -0500 | Rating Details | |
| 2023-08-18 18:15:52 -0500 | Rating Details | |
| 2023-08-18 17:15:49 -0500 | Rating Details | |
| 2023-08-18 16:21:56 -0500 | Rating Details | |
| 2023-08-18 16:12:39 -0500 | Rating Details | |
| 2023-08-18 16:03:29 -0500 | Rating Details | |
| 2023-08-18 15:55:31 -0500 | Rating Details | |
| 2023-08-18 15:46:49 -0500 | Rating Details | |
| 2023-08-18 15:03:12 -0500 | Rating Details | |
| 2023-08-18 14:34:25 -0500 | Rating Details | |
| 2023-08-18 14:34:13 -0500 | Rating Details | |
| 2023-08-18 14:24:52 -0500 | Rating Details | |
| 2023-08-18 14:06:40 -0500 | Rating Details | |
| 2023-08-18 13:32:58 -0500 | Rating Details | |
| 2023-08-18 13:31:25 -0500 | Rating Details | |
| 2023-08-18 13:13:59 -0500 | Rating Details | |
| 2023-08-18 11:55:50 -0500 | Rating Details | |
| 2023-08-18 11:47:49 -0500 | Rating Details | |
| 2023-08-18 11:28:37 -0500 | Rating Details | |
| 2023-08-18 11:05:38 -0500 | Rating Details | |
| 2023-08-18 10:08:07 -0500 | Rating Details | |
| 2023-08-18 09:59:42 -0500 | Rating Details | |
| 2023-08-18 09:17:36 -0500 | Rating Details | |
| 2023-08-18 09:14:23 -0500 | Rating Details | |
| 2023-08-18 09:08:30 -0500 | Rating Details | |
| 2023-08-18 07:56:14 -0500 | Rating Details | |
| 2023-08-18 07:25:47 -0500 | Rating Details | |
| 2023-08-18 07:19:46 -0500 | Rating Details | |
| 2023-08-18 06:43:45 -0500 | Rating Details | |
| 2023-08-18 06:41:09 -0500 | Rating Details | |
| 2023-08-18 06:35:33 -0500 | Rating Details | |
| 2023-08-18 06:23:44 -0500 | Rating Details | |
| 2023-08-18 06:17:32 -0500 | Rating Details | |
| 2023-08-20 15:57:34 -0500 | Rating Details | |
| 2023-08-20 03:42:04 -0500 | Rating Details | |
| 2023-08-21 14:15:07 -0500 | Rating Details | |
| 2023-08-21 12:55:28 -0500 | Rating Details | |
| 2023-08-22 07:00:11 -0500 | Rating Details | |
| 2023-08-21 21:10:45 -0500 | Rating Details | |
| 2023-08-19 02:19:56 -0500 | Rating Details | |
| 2023-08-19 00:41:53 -0500 | Rating Details | |
| 2023-08-18 19:50:19 -0500 | Rating Details | |
| 2023-08-18 11:23:34 -0500 | Rating Details | |
| 2023-08-18 06:08:17 -0500 | Rating Details | |
| 2023-08-23 16:09:16 -0500 | Rating Details | |
| 2023-08-23 15:56:57 -0500 | Rating Details | |
| 2023-08-23 15:48:34 -0500 | Rating Details | |
| 2023-08-23 21:31:10 -0500 | Rating Details | |
| 2023-08-23 20:57:20 -0500 | Rating Details | |
| 2023-08-25 02:24:26 -0500 | Rating Details | |
| 2023-08-29 06:37:46 -0500 | Rating Details |